Invitae Co. (NYSE:NVTA – Get Rating) has received a consensus rating of “Hold” from the twelve research firms that are presently covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average twelve-month price target among brokers that […]
Invitae Co. (NYSE:NVTA – Get Rating) has been assigned an average recommendation of “Hold” from the twelve brokerages that are presently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average 12 month price objective among analysts […]
SG Americas Securities LLC raised its holdings in shares of Invitae Co. (NYSE:NVTA – Get Rating) by 177.6% in the 3rd quarter, HoldingsChannel reports. The firm owned 138,631 shares of the medical research company’s stock after buying an additional 88,688 shares during the period. SG Americas Securities LLC’s holdings in Invitae were worth $341,000 as […]
Shares of Invitae Co. (NYSE:NVTA – Get Rating) have received an average recommendation of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have assigned a buy recommendation to the company. […]
Shares of Invitae Co. (NYSE:NVTA – Get Rating) hit a new 52-week low on Monday after Benchmark lowered their price target on the stock from $13.00 to $6.00. Benchmark currently has a buy rating on the stock. Invitae traded as low as $2.15 and last traded at $2.20, with a volume of 191972 shares. The […]